Erratum: Development and Validation of a Risk Scoring System Derived from Meta-Analyses for Papillary Thyroid Cancer (Endocrinol Metab (2020) 35 (435-442) DOI: 10.3803/EnM.2020.35.2.435)

This corrects the article “Development and validation of a risk scoring system derived from meta-analyses for papillary thyroid cancer” in Volume 35 on page 435. There was an error in our recently published article in the affiliation of the corresponding author, which should be revised as follows. Department of Nuclear Medicine and Biomedical Research Institute, Pusan National University Hospital, Busan, Korea → Department of Nuclear Medicine and Biomedical Research Institute, Pusan National University Hospital and School of Medicine, Pusan National University, Busan, Korea We would like to apologize for any inconvenience or misunderstanding.